診断イメージング装置の世界市場：2024年～2031年

レポート概要

診断イメージング装置の世界市場は、2023年の445億米ドルから、2031年には660億6,000万米ドルに達し、予測期間2024-2031年のCAGRで5.2%の成長が予測されています。

診断イメージングとは、病気や怪我の原因を解明し、診断を確定するために体の内部を見る様々な技術を指します。診断ヘルスイメージング技術はヘルスケアを一変させ、現在では病状の早期診断を可能にし、不必要な侵襲的探索プロセスの必要性を減らし、より良い患者の転帰を生み出しています。診断イメージング技術は、整形外科、神経科、産婦人科、腫瘍科、循環器科、歯科など様々な医療分野で応用されています。

診断イメージングとは、患者の体内構造や臓器の視覚的な画像を得ることで、病気や怪我を診断・監視するための非侵襲的な画像検査の医療技術です。診断イメージング技術は、医師が患者の病状を正確に検査・診断するために広く使用されています。心臓の異常、骨折、動脈瘤、胃腸の問題、様々な種類のがんの特定に役立っています。診断イメージングはまた、治療に対する患者の体の反応をモニターするためにも用いられます。診断イメージングは病気を早期に診断し、患者の生存率を大幅に向上させる。診断イメージングは痛みを伴わず、迅速な診断が可能です。診断イメージング業界は、ベッドサイドでのモニタリングからハイエンドのデジタルスキャニングへと変革を遂げています。

市場力学：

促進要因

慢性疾患の増加

様々な慢性疾患の有病率が上昇していることが、市場の成長を後押ししています。例えば、2023年1月にnih.govが発表した記事によると、2023年には米国で195万8310人の新規がん患者と60万9820人のがん死亡者が発生すると予測されています。前立腺がんの罹患率は、20年間減少した後、2014年から2019年にかけて毎年3％増加し、99,000人の新規症例が追加されることになります。

さらに、wcrf.orgによると、非黒色腫皮膚がん（NMSC）を含めると、2022年には19,976,499人のがん患者が発生します。NMSCを除くと、2022年には世界中で18,741,966人のがん患者が発生します。このうち、男性が956万6,825人、女性が917万5,141人です。さらに、IARCによれば、2022年に新たに発生するがん（非黒色腫皮膚がん［NMSC］を含む）は2,000万件に迫り、がんによる死亡者（NMSCを含む）は970万人に上ります。推計によると、生涯にがんに罹患するのは男性または女性の約5人に1人で、死亡するのは男性の約9人に1人、女性の約12人に1人です。肺がんは2022年に最も多く診断されるがんで、約250万人の新規症例、すなわち世界のがんの8人に1人（世界の全がんの12.4％）を占める。

抑制要因

治療に伴う高額な費用、医療インフラの不足、熟練した専門家の不足などの要因が市場の妨げになると予想されます。

市場セグメンテーション

世界の診断イメージング装置市場は、製品タイプ、用途、エンドユーザー、地域によって区分されます。

診断イメージング装置の世界市場シェアはX線が約48.6%を占める

予測期間中、X線セグメントが最大の市場シェアを占めると予測されています。この分野では、技術の進歩が市場を牽引しています。

X線は電磁放射線の一種で、可視光線に似ています。しかし、光とは異なり、X線はエネルギーが高く、人体を含むほとんどの物体を通過することができます。医療用X線は、体内の組織や構造の画像を生成するために使用されます。体内を透過したX線が患者の反対側にあるX線検出器も通過すると、体内の物体によって形成された「影」を表す画像が形成されます。

例えば、ケアストリームヘルスは2024年1月、ワークフローの簡素化と生産性の向上を目的とした機能を備えた新しいX線撮影システム「DXR-Excel Plus」を発売しました。DXR-Excel Plusは、透視検査と一般的な放射線検査の両方に対応する2in1システムで、幅広い検査に対応するリアルタイム画像を提供する一方、ユーザー、患者、管理者のエクスペリエンスを向上させる機能を備えています。

市場の地域別シェア

北米が診断イメージング装置の世界市場シェアの約42.8%を占める

予測期間中、北米地域が最大の市場シェアを占めると予想されます。同地域では、慢性疾患の罹患率の上昇や技術の進歩が市場の推進力となっています。

例えば、nih.govが2024年1月に発表した記事によると、2024年には米国で新たに2,001,140人のがん患者と611,720人のがん死亡者が発生すると予測されています。がん死亡率は2021年まで低下し続け、1991年以来400万人以上の死亡が回避されました。これは、喫煙の減少、一部のがんの早期発見、補助療法と転移の両方における治療選択肢の改善によるものです。しかし、上位10がんのうち6がんの罹患率が上昇しているため、これらの利益は脅かされています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 慢性疾患の増加
  • 抑制要因
    • 処置に伴う高コスト
    • 医療インフラの不足
    • 熟練した専門家の不足
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• アンメットニーズ
• PESTEL分析
• 特許分析
• SWOT分析

第6章 製品タイプ別

• X線
• CT
• 超音波
• MRI
• 核医学イメージング
• 触覚イメージング
• 光音響イメージング
• サーモグラフィ
• エラストグラフィ
• 心エコー検査
• fNIRS（赤外分光分析法）
• マンモグラフィ

第7章 用途別

• 心臓病
• 整形外科
• 消化器
• 婦人科
• 腫瘍
• 神経科
• その他

第8章 エンドユーザー別

• 病院・クリニック
• 診断イメージングセンター
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• GE Healthcare
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Shimadzu Corporation
• Koninklijke Philips N.V
• Genesis Medical Imaging Inc.
• Hologic Inc.
• Siemens Healthcare
• Samsung Medison Co. Ltd.
• Carestream Health Inc.
• Hitachi Medical Corporation
• Toshiba Corporation

第12章 付録

Report Overview

The Global Diagnostic Imaging Equipment Market reached US$ 44.5 billion in 2023 and is expected to reach US$ 66.06 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.

Diagnostic imaging describes various techniques of viewing the inside of the body to help figure out the causes of an illness or injury and confirm a diagnosis. Diagnostic health imaging technology has transformed healthcare and now allows for earlier diagnosis of medical conditions, reduces the need for needless invasive exploratory processes, and creates better patient outcomes. Diagnostic imaging technology is applied in various fields of medicine like orthopedics, neurology, obstetrics/gynecology, oncology, cardiology, dental, and others.

Diagnostic imaging is a medical technique of non-invasive imaging tests for diagnosing and monitoring diseases or injuries by getting visual images of internal structures and organs of the patient's body. Diagnostic imaging technologies are used extensively by doctors to examine and diagnose the exact medical conditions of patients. It helps identify cardiac abnormalities, broken bones, aneurysms, gastrointestinal issues, and various types of cancer. Diagnostic imaging is also used to monitor how the patient's body responds to the treatment being given. Diagnostic imaging diagnoses disease early and significantly improves patient survival outcomes. It is a painless technique and offers a rapid diagnosis. The diagnostic imaging industry has been revolutionized from bedside monitoring to high-end digital scanning.

Market Dynamics: Drivers

Increasing prevalence of chronic diseases

The rising prevalence of various chronic diseases propels the market growth. For instance, according to an article published by nih.gov in January 2023, in 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases.

Moreover, according to wcrf.org, including non-melanoma skin cancer (NMSC) there were 19,976,499 cancer cases in 2022. When NMSC was excluded, this number dropped to 18,741,966 cancer cases around the world in 2022. Of these, 9,566,825 were in men and 9,175,141 in women. Moreover, according to IARC, There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally).

Restraints

Factors such as high cost associated with the treatment, lack of healthcare infrastructure, and shortage of skilled professionals are expected to hamper the market are expected to hamper the market.

Market Segment Analysis

The global diagnostic imaging equipment market is segmented based on product type, application, end-user, and region.

The X-ray accounted for approximately 48.6% of the global diagnostic imaging equipment market share

The X-ray segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements drive this market.

X-rays are a form of electromagnetic radiation, similar to visible light. Unlike light, however, x-rays have higher energy and can pass through most objects, including the body. Medical X-rays are used to generate images of tissues and structures inside the body. If X-rays traveling through the body also pass through an X-ray detector on the other side of the patient, an image will be formed that represents the "shadows" formed by the objects inside of the body.

For instance, in January 2024, Carestream Health launched a new x-ray system called DXR-Excel Plus with features designed to help simplify workflow and enhance productivity. DXR-Excel Plus is a two-in-one system for both fluoroscopy and general radiology that delivers real-time, images for a wide range of exams while providing features that help create an enhanced experience for users, patients, and administrators.

Market Geographical Share

North America accounted for approximately 42.8% of the global diagnostic imaging equipment market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of chronic diseases, and technological advancements, in this region, help to propel the market.

For instance, according to an article published by nih.gov in January 2024, 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers.

Moreover, in June 2024, Smiths Detection launched its latest X-ray scanner powered by diffraction technology SDX 10060 XDi. X-ray Diffraction (XRD) is a powerful inspection technology offering highly accurate material discrimination and substance identification based on an object's molecular structure. XRD is particularly suited to detecting constantly evolving compounds in powder, liquid, or solid forms, such as 'homemade' explosives or narcotics, even for materials with similar densities.

Market Segmentation

By Product Type

X-ray

Computed Tomography

Ultrasound

Magnetic Resonance Imaging

Nuclear Imaging

Tactile Imaging

Photoacoustic Imaging

Thermography

Elastography

Echocardiography

Functional Near-Infrared Spectroscopy

Mammography

By Application

Cardiology

Orthopedics

Gastroenterology

Gynecology

Oncology

Neurology

Others

By End-User

Hospitals And Clinics

Diagnostic Imaging Centers

Other

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the global diagnostic imaging equipment market include GE Healthcare, Shimadzu Corporation, Philips Healthcare, Genesis Medical Imaging Inc., Hologic Inc., Siemens Healthcare, Samsung Medison Co. Ltd, Carestream Health Inc., Hitachi Medical Corporation and Toshiba Corporation among others.

Key Developments

In February 2024, Philips Healthcare announced the launch of a new light-based catheter guidance system for cath labs that represents a step toward radiation-free interventional imaging. The focus of the technology right now is endovascular aortic procedures.

In March 2024, Philips Healthcare introduced a new computed tomography system this week at the European Congress of Radiology (ECR) aimed at the rapidly growing cardiac coronary CT angiography (CCTA) market. It features a new detector that was designed to optimize the use of artificial intelligence (AI) image reconstruction algorithms. The new CT 5300 system provides more accurate and reliable imaging results to better manage the increase in complex cardiac cases.

In February 2024, A&M Life Solutions, a certified public procurement supplier of medical devices/healthcare services in collaboration with Fujifilm, launched a mobile X-ray device into the market known as the Fujifilm Xair, the device is a mobile X-ray solution with AI, mainly for Occupational Healthcare. It can generate reports on site for most communicable diseases such as Tuberculosis (TB), COVID-19, etc for chest-related issues, extremities, and emergencies or accident X-ray diagnoses.

Why Purchase the Report?

To visualize the global diagnostic imaging equipment market segmentation based on product type, application, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global diagnostic imaging equipment market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global diagnostic imaging equipment market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Chronic Diseases
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost Associated with Procedures
    • 4.1.2.2. Lack of Healthcare Infrastructure
    • 4.1.2.3. Shortage of Skilled Professionals
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs
• 5.6. PESTEL Analysis
• 5.7. Patent Analysis
• 5.8. SWOT Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. X-Ray*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Computed Tomography
• 6.4. Ultrasound
• 6.5. Magnetic Resonance Imaging
• 6.6. Nuclear Imaging
• 6.7. Tactile Imaging
• 6.8. Photoacoustic Imaging
• 6.9. Thermography
• 6.10. Elastography
• 6.11. Echocardiography
• 6.12. Functional Near Infrared Spectroscopy
• 6.13. Mammography

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Cardiology*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Orthopedics
• 7.4. Gastroenterology
• 7.5. Gynecology
• 7.6. Oncology
• 7.7. Neurology
• 7.8. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals and Clinics*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Diagnostic Imaging Centers
• 8.4. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. The U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. GE Healthcare *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Shimadzu Corporation
• 11.3. Koninklijke Philips N.V
• 11.4. Genesis Medical Imaging Inc.
• 11.5. Hologic Inc.
• 11.6. Siemens Healthcare
• 11.7. Samsung Medison Co. Ltd.
• 11.8. Carestream Health Inc.
• 11.9. Hitachi Medical Corporation
• 11.10. Toshiba Corporation (*LIST NOT EXHAUSTIVE)

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us